Tweet This

Patient-centered Care

Model for care delivery that accounts for the needs and preferences of patients and their families.

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is…